In reply to: Enalapril and the VEGFA gene: personalized medicine in hypertension therapy

被引：0
|
作者：
G. H. Oliveira-Paula
R. Lacchini
J. E. Tanus-Santos
机构：
[1] University of Sao Paulo,Department of Pharmacology, Ribeirao Preto Medical School
[2] University of Sao Paulo,Department of Psychiatric Nursing and Human Sciences, Ribeirao Preto College of Nursing
来源：
European Journal of Clinical Pharmacology | 2016年 / 72卷
关键词：
Nitric Oxide; Vascular Endothelial Growth Factor; Hypertensive Patient; Enalapril; Bradykinin;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：127 / 128
页数：1
相关论文
共 26 条
  • [1] Enalapril and the VEGFA gene: Personalized medicine in hypertension therapy
    Firoj Kumar Sahoo
    European Journal of Clinical Pharmacology, 2016, 72 : 125 - 125
  • [2] Enalapril and the VEGFA gene: Personalized medicine in hypertension therapy
    Sahoo, Firoj Kumar
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2016, 72 (01) : 125 - 125
  • [3] In reply to: Enalapril and the VEGFA gene: personalized medicine in hypertension therapy
    Oliveira-Paula, G. H.
    Lacchini, R.
    Tanus-Santos, J. E.
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2016, 72 (01) : 127 - 128
  • [4] Polymorphisms in VEGFA gene affect the antihypertensive responses to enalapril
    Oliveira-Paula, G. H.
    Lacchini, R.
    Fontana, V.
    Silva, P. S.
    Biagi, C.
    Tanus-Santos, Jose E.
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2015, 71 (08) : 949 - 957
  • [5] Polymorphisms in VEGFA gene affect the antihypertensive responses to enalapril
    G. H. Oliveira-Paula
    R. Lacchini
    V. Fontana
    P. S. Silva
    C. Biagi
    Jose E. Tanus-Santos
    European Journal of Clinical Pharmacology, 2015, 71 : 949 - 957
  • [6] Personalized medicine in pulmonary hypertension
    Milger-Kneidinger, K.
    PNEUMOLOGE, 2019, 16 (02): : 76 - 87
  • [7] Effects of long-term enalapril and losartan therapy of hypertension on cardiovascular aldosterone
    Li, SM
    Wu, PS
    Zhong, SS
    Guo, ZG
    Lai, WY
    Zhang, YH
    Liang, XW
    Xiu, JC
    Li, JH
    Liu, YL
    HORMONE RESEARCH, 2001, 55 (06) : 293 - 297
  • [8] Tasosartan and hydroclorothiazide as combination therapy in the treatment of severe essential hypertension:: Comparison with enalapril
    Viigimaa, M
    Allikmets, K
    Parik, T
    Skards, J
    Franken, A
    Häss, G
    CARDIOVASCULAR DRUGS AND THERAPY, 2000, 14 (04) : 447 - 449
  • [9] Tasosartan and Hydroclorothiazide as Combination Therapy in the Treatment of Severe Essential Hypertension: Comparison with Enalapril
    M. Viigimaa
    K. Allikmets
    T. Parik
    J. Skards
    A. Franken
    G. Häass
    Cardiovascular Drugs and Therapy, 2000, 14 : 447 - 449
  • [10] Oral therapy with combined enalapril, prazosin and hydrochlorothiazide in the acute treatment of severe hypertension in Nigerians
    Ajayi, AA
    Afolabi, MA
    Balogun, MO
    Adigun, AQ
    Ajayi, OE
    Akintomide, AO
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1996, 51 (01) : 45 - 48
123